1. Home
  2. ABP vs FLGC Comparison

ABP vs FLGC Comparison

Compare ABP & FLGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABP
  • FLGC
  • Stock Information
  • Founded
  • ABP N/A
  • FLGC 2019
  • Country
  • ABP United States
  • FLGC United States
  • Employees
  • ABP N/A
  • FLGC N/A
  • Industry
  • ABP Biotechnology: Pharmaceutical Preparations
  • FLGC Biotechnology: Pharmaceutical Preparations
  • Sector
  • ABP Health Care
  • FLGC Health Care
  • Exchange
  • ABP Nasdaq
  • FLGC Nasdaq
  • Market Cap
  • ABP 29.8M
  • FLGC 26.5M
  • IPO Year
  • ABP 2022
  • FLGC 2021
  • Fundamental
  • Price
  • ABP N/A
  • FLGC $1.17
  • Analyst Decision
  • ABP
  • FLGC Strong Buy
  • Analyst Count
  • ABP 0
  • FLGC 3
  • Target Price
  • ABP N/A
  • FLGC $6.50
  • AVG Volume (30 Days)
  • ABP N/A
  • FLGC 533.2K
  • Earning Date
  • ABP N/A
  • FLGC 11-13-2024
  • Dividend Yield
  • ABP N/A
  • FLGC N/A
  • EPS Growth
  • ABP N/A
  • FLGC N/A
  • EPS
  • ABP N/A
  • FLGC N/A
  • Revenue
  • ABP N/A
  • FLGC $64,154,000.00
  • Revenue This Year
  • ABP N/A
  • FLGC N/A
  • Revenue Next Year
  • ABP N/A
  • FLGC $19.90
  • P/E Ratio
  • ABP N/A
  • FLGC N/A
  • Revenue Growth
  • ABP N/A
  • FLGC N/A
  • 52 Week Low
  • ABP N/A
  • FLGC $0.70
  • 52 Week High
  • ABP N/A
  • FLGC $2.93
  • Technical
  • Relative Strength Index (RSI)
  • ABP N/A
  • FLGC 40.65
  • Support Level
  • ABP N/A
  • FLGC $1.11
  • Resistance Level
  • ABP N/A
  • FLGC $1.63
  • Average True Range (ATR)
  • ABP 0.00
  • FLGC 0.18
  • MACD
  • ABP 0.00
  • FLGC -0.05
  • Stochastic Oscillator
  • ABP 0.00
  • FLGC 6.67

About FLGC Flora Growth Corp.

Flora Growth Corp is a multi-national cannabis company that manufactures and distributes consumer packaged goods, cultivates and distributes medicinal cannabis, and distributes pharmaceutical products. Its reportable segments are; the commercial and wholesale segment (FGH and Cosechemos subsidiaries), the house of brands segment (JustCBD, Vessel, and Kasa Wholefoods Company subsidiaries), and the pharmaceuticals segment (Grupo Farmaceutico Cronomed and Breeze Laboratory subsidiaries). Geographically, the company generates revenue from United States, Germany, and the United Kingdom. It derives a majority of its revenue from the United States.

Share on Social Networks: